Articles From: Absolute Software Launches Earth Day Angels Campaign to Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks


2013/4/16
Absolute Software Launches Earth Day Angels Campaign Canada NewsWire Absolute Earth Day Angels Encourage Everyone to Pledge Their Act of Green VANCOUVER , April 16, 2013 /CNW/ - Absolute® Software Corporation (TSX: ABT) , the industry standard for persistent endpoint security and management solutions for computers, laptops and ultra-portable devices, today announced the launch of the Earth Day Angels Campaign in support of A Billion Acts of Green® .
Sign-up for Absolute Software Launches Earth Day Angels Campaign investment picks
2013/4/16
Absolute Earth Day Angels Encourage Everyone to Pledge Their Act of Green VANCOUVER , April 16, 2013 /PRNewswire/ - Absolute® Software Corporation (TSX: ABT) , the industry standard for persistent endpoint security and management solutions for computers, laptops and ultra-portable devices, today announced the launch of the Earth Day Angels Campaign in support of A Billion Acts of Green® .
Sign-up for Absolute Software Launches Earth Day Angels Campaign investment picks
2013/4/16
Accord Declares Regular Quarterly Dividend of 8.0 Cents per Share Canada NewsWire SOURCE: Accord Financial Corp.
Sign-up for Accord Declares Regular Quarterly Dividend of 8.0 Cents per Share investment picks
2013/4/16
NEW HAVEN, Conn., April 16, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that it has initiated an international Phase 2 clinical trial with sovaprevir and ACH-3102 for the treatment of genotype 1 chronic hepatitis C (HCV). The trial will evaluate an all-oral 12-week interferon-free regimen consisting of sovaprevir, ACH-3102, and ribavirin in patients with chronic HCV who have not received prior therapy.
Sign-up for Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV investment picks
2013/4/16
ACI Worldwide, Inc. (NASDAQ: ACIW) , a leading international provider of electronic payments software and solutions, announced today that it will report its financial results for the first quarter 2013 on May 2, 2013.
Sign-up for ACI Worldwide, Inc. To Release First Quarter 2013 Financial Results investment picks
2013/4/16
http://media.marketwire.com/attachments/201202/12010_ActivePowerLogoHighRes.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1007704&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Active Power Sets First Quarter 2013 Conference Call for April 30 at 4:30 p.m. ET investment picks
2013/4/16
ATLANTA , April 16, 2013 /PRNewswire/ -- AdCare Health Systems, Inc. (NYSE MKT: ADK) (NYSE MKT: ADK.PRA), a leading long-term care provider, today announced that the filing of the Company's Annual Report on Form 10-K for the year ended December 31, 2012 , and the previously announced restatements of the Company's financial statements for the quarters ended March 31, 2012 , June 30, 2012 and September 30, 2012 , will be delayed beyond April 16, 2013 (the extended filing deadline for the Form 10-K). The Company is also furnishing in this release preliminary unaudited: (a) consolidated balance sheet as of December 31, 2012 ; and (b) consolidated statement of operations for the quarters ended March 31, 2012 , June 30, 2012 , September 30, 2012 and December 31, 2012 and the year ended December 31, 2012 .
Sign-up for AdCare Health Systems Provides Update on Status of Annual Report on Form 10-K and Releases Preliminary Unaudited Financial Information for 2012 investment picks
2013/4/16
International companies trading in New York closed higher Tuesday, bouncing-back some after a steep slide Monday.
Sign-up for ADR Shares End Higher, Rebounding From Monday's Slide investment picks
2013/4/16
Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced that Chairman and CEO Gary Rabin will present at the Alliance for Regenerative Medicine’s first annual Regen Med Investor Day on Wednesday, April 17, 2013 in New York City.
Sign-up for Advanced Cell Technology to Present at Regen Med Investor Day 2013 investment picks
2013/4/16
FORT COLLINS, Colo., April 16, 2013 (GLOBE NEWSWIRE) -- Advanced Energy Industries, Inc. (Nasdaq:AEIS) will release first quarter 2013 financial results after market close on Monday, April 29, 2013.
Sign-up for Advanced Energy to Announce First Quarter 2013 Results on April 30th Before Market Open investment picks
2013/4/16
CAMBRIDGE, Mass., April 16, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc.   (Nasdaq:AEGR) , a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal rare diseases, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EDT on Tuesday, April 30, 2013, to provide a business update and to discuss its first-quarter financial and operational results.
Sign-up for Aegerion Pharmaceuticals to Announce First Quarter 2013 Financial Results on Tuesday, April 30 investment picks
2013/4/16
Aetna (NYSE: AET ) is making it easier for mid-sized employers to provide health benefits directly to employees and assume the financial risk for their employees’ claims, with Aetna’s administrative support.
Sign-up for Aetna Helps Mid-Sized Employers Move to Self-Funding investment picks
2013/4/16
In the wake of the tragedy at the Boston Marathon, Aetna (NYSE: AET ), has opened its student and employee assistance program lines for any person who may be having difficulty coping with this senseless act of violence.
Sign-up for Aetna Opens Support Lines to the Public Following Explosions at Boston Marathon investment picks
2013/4/16
MOSCOW --Russian conglomerate AFK Sistema doesn't yet have any plans for a share buyback and instead plans to focus on the company dividends, the company's Chief Executive Mikhail Shamolin told reporters Tuesday.
Sign-up for AFK Sistema: No Plan For Buyback, Focus on Dividend investment picks
2013/4/16
AGCO, Your Agriculture Company, (NYSE:AGCO) , a worldwide manufacturer and distributor of agricultural equipment, announced today its 2013 First Quarter Earnings Release Conference Call is scheduled for Tuesday, April 30th at 10:00 a.m. EDT.
Sign-up for AGCO Announces 2013 First Quarter Earnings Release and Conference Call investment picks
2013/4/16
LEHIGH VALLEY, Pa.
Sign-up for Air Products Announces North American Price Increase for Liquid and Bulk Industrial Gas Products investment picks
2013/4/16
Air Products & Chemicals Inc. (APD) plans to raise prices on some of its products in North America by as much as 10% starting next month as the company faces higher costs to produce and deliver its industrial gases.
Sign-up for Air Products Plans to Raise Prices in North America by Up to 10% in May investment picks
2013/4/16
Allegheny Technologies Incorporated (NYSE: ATI) announced today that it expects first quarter 2013 net income attributable to ATI to be approximately $10 million, or $0.09 per share, on sales of approximately $1.18 billion.
Sign-up for Allegheny Technologies Comments on First Quarter 2013 investment picks
2013/4/16
FORT WORTH, Texas, April 16, 2013 (GLOBE NEWSWIRE) -- Allied Electronics, a trading brand of Electrocomponents plc (LSE:ECM) , recently updated its newsroom at www.alliedelec.com .
Sign-up for Allied Electronics Updates Newsroom investment picks
2013/4/16
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide, (LAMA) and formoterol fumarate (LABA) delivered by Almirall’s inhaler Genuair ® (Pressair™ in the USA). Both combinations of aclidinium/formoterol (400/6mcg and 400/12mcg given twice a day) demonstrated statistically significant improvements in the co-primary endpoints of change from baseline in morning predose trough FEV1 versus formoterol 12mcg and in FEV1 at 1 hour post-dose versus aclidinium 400mcg at week 24 (p<0.01 and p≤0.0001, respectively). In addition, both combinations of aclidinium/formoterol (400/6mcg and 400/12mcg) provided statistically significant improvements versus placebo in the above two variables (both
Sign-up for Almirall and Forest Laboratories Announce Positive Phase III Study Results for Aclidinium and Formoterol Combination in COPD investment picks
2013/4/16
Almirall and Forest Laboratories Announce Positive Results of a Phase III Study for Aclidinium and Formoterol Combination in COPD Canada NewsWire BARCELONA AND NEW YORK, April 16, 2013 /CNW/ - Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair ®  (Pressair™ in the USA). Both combinations of aclidinium/formoterol (400/6mcg and 400/12mcg twice a day) demonstrated statistically significant improvements in the co-primary endpoints of change from baseline in morning predose trough FEV1 versus formoterol 12mcg and in FEV1 at 1 hour post-dose versus aclidinium 400mcg both at week 24 (p<0.01 and p≤0.0001, respectively). In addition, both combinations of aclidinium/formoterol
Sign-up for Almirall and Forest Laboratories Announce Positive Results of a Phase III Study for Aclidinium and Formoterol Combination in COPD investment picks
2013/4/16
ZURICH --
Sign-up for Amara Mining Considering Several Joint Venture Approaches investment picks
2013/4/16
SPOKANE, Wash., April 16, 2013 (GLOBE NEWSWIRE) -- Ambassadors Group, Inc. (Nasdaq:EPAX) , a leading provider of educational travel experiences and online education research materials, today announced that its Board of Directors has suspended the Company's quarterly dividend to preserve liquidity and enhance the Company's financial flexibility.
Sign-up for Ambassadors Group, Inc. Suspends Quarterly Dividend investment picks
2013/4/16
Pre-integrated Wi-Fi control and monetization solution enables seamless access between 3G/4G networks and Wi-Fi for optimal customer experience BERLIN , April 16, 2013 /PRNewswire/ -- At the Policy Control and Data Pricing event, Amdocs (NYSE: DOX) , the leading provider of customer experience systems and services, today introduced the Amdocs Wi-Fi Experience Solution, a pre-integrated Wi-Fi control and monetization solution that enables mobile and fixed broadband service providers to accelerate the introduction of innovative Wi-Fi services.
Sign-up for Amdocs Introduces Wi-Fi Experience Solution, Enabling Service Providers to Quickly Launch New Wi-Fi Services investment picks
2013/4/16
--Revenue seen up 0.9% from a year ago, affected by peso strength --Migration to mobile data services to continue squeezing margins --Regulatory pressure still a drag on company's share price By Anthony Harrup MEXICO CITY --Mexican telecommunications heavyweight America Movil SAB (AMX, AMX.MX) is expected to report lower earnings for the first quarter as increasing migration to smartphones raises costs, offsetting modest gains in revenue.
Sign-up for America Movil Seen Reporting Lower First-Quarter Earnings investment picks
2013/4/16
NEW YORK , April 16, 2013 /PRNewswire/ --   American Realty Capital Properties, Inc. ("ARCP") (NASDAQ:ARCP) announced today that, since its last announcement on April 8, 2013 , it has closed an additional $14 million of single tenant net lease acquisitions, including six properties leased to four high-quality, investment grade or credit-worthy tenants, including CVS, Family Dollar, Hy-Vee and Advance Auto.
Sign-up for American Realty Capital Properties Announces $14 Million of Acquisitions and Continues to Diversify its Tenant Base investment picks
2013/4/16
JOHNSTOWN, Pa.
Sign-up for AmeriServ Financial Reports Earnings For The First Quarter Of 2013 investment picks
2013/4/16
Amgen Inc. (AMGN) will pay $24.9 million to settle allegations that it paid kickbacks to certain long-term care pharmacy providers, the Justice Department said.
Sign-up for Amgen to Pay $24.9 Million to Settle Kickbacks Allegations investment picks
2013/4/16
Amgen Inc. (AMGN) will pay $24.9 million to settle allegations that it paid kickbacks to certain long-term care pharmacy providers, the Justice Department said.
Sign-up for Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Absolute Software Launches Earth Day Angels Campaign to Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity